Abstract:Introduction Prenatal opioid exposure (POE) is a major public health consequence of the opioid epidemic. Long‐term health outcomes associated with POE remain unclear, especially for children with POE without a diagnosis of neonatal abstinence syndrome (NAS). Here, we aimed to describe the health outcomes of children with POE and with POE and NAS compared to unexposed children during the first 7 years of life. Design In this retrospective observational cohort study, children born between 2015 and 2022 were identified from the Maternal and Infant Data Hub (MIDH), a data repository that continuously integrates maternal, neonatal, and pediatric records from two academic medical centers and one pediatric hospital system in the Midwest, USA. Methods International Classification of Diseases, 10th Revision, Clinical Modification (ICD‐10 CM) chapters A00‐N99 served as outcomes of interest. Annual incidence and crude incidence rate ratios were calculated to explore descriptive differences between the exposed and unexposed groups. Results The study included 22,002 children, 20,130 (91.5%) of whom were unexposed and 1872 (8.5%) were exposed. Of the 1872 exposed children, 371 (19.8%) received a diagnosis of NAS (POE + NAS) and 1501 were in the POE‐NAS group. Across all 7 years, exposed children had a higher incidence of diagnoses in most ICD‐10 CM chapters compared to unexposed children. A consistently higher incidence rate ratio of diagnosis was observed in both POE‐NAS and POE + NAS groups (vs. unexposed) related to mental and behavioral disorders, eye diagnoses, and diseases of the musculoskeletal system and gastrointestinal systems. Conclusions POE is associated with an increased risk of diagnoses in a number of ICD‐10 CM chapters throughout childhood. These findings underscore the need for early screening and targeted interventions to support exposed children and improve their well‐being. Further research is required to explore underlying mechanisms and develop preventive measures for at‐risk populations. Clinical Relevance Understanding the conditions more often diagnosed in children with prenatal opioid exposure will help to improve care provided to this population. As a result of study findings, nurses who provide care to children with prenatal opioid exposure can prioritize their assessments and allocate time, resources, and education toward areas more likely to be affected.

Chapter 8: The Role of Genetics in Neonatal Abstinence Syndrome

Molecular and Long-Term Behavioral Consequences of Neonatal Opioid Exposure and Withdrawal in Mice.

Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment

Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids

Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity

Gut Microbiota and Symptom Expression and Severity in Neonatal Abstinence Syndrome

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Neonatal Abstinence Syndrome and Corresponding Pharmacotherapy Approaches from 2 University-affiliated Neonatal Intensive Care Units in Puerto Rico (2018-2020)

Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome

Neonatal Abstinence Syndrome and High School Performance

Health outcomes in children with prenatal opioid exposure with and without neonatal abstinence syndrome in the first seven years of life: An observational cohort study

Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications

Development and Validation of a Model to Predict Neonatal Abstinence Syndrome

Current management of neonatal abstinence syndrome: a survey of practice in the UK and Ireland

The Role of Stigma in the Nursing Care of Families Impacted by Neonatal Abstinence Syndrome

Consequences of Parental Opioid Exposure on Neurophysiology, Behavior, and Health in the Next Generations

HHS releases standard definition for opioid withdrawal in infants

Prenatal buprenorphine/naloxone exposure and neonatal neurobehavioral functioning: A preliminary report